Literature DB >> 12803125

Chronic myeloid leukemia in a patient with colon adenocarcinoma.

Yüksel Gokel1, Semra Paydas.   

Abstract

A 62-year-old male patient who developed Philadelphia chromosome-positive chronic myeloid leukemia (CML) after cisplatin and 5-fluorouracil treatment for colon adenocarcinoma is reported. CML has been described after therapy for other malignancies, but no case of CML has been reported following treatment for colon carcinoma. It is not clear whether the development of CML after colon adenocarcinoma represents a therapy-related secondary malignancy, a coincidence, or an increased susceptibility to secondary malignancies due to the malignant process itself. Here we reported a case with colon adenocarcinoma and later developing CML which is not reported so far in according to our knowledge.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12803125

Source DB:  PubMed          Journal:  Haematologia (Budap)        ISSN: 0017-6559


  4 in total

1.  Chronic myeloid leukemia following colon cancer treatment: A case report and literature review.

Authors:  Mohsen Vakili-Sadeghi; Mohammadhasan Omranpour
Journal:  Caspian J Intern Med       Date:  2013

2.  Chronic myelogenous leukemia after postoperative adjuvant S-1 therapy for rectal cancer: a case report.

Authors:  Masahiro Manabe; Takafumi Nishii; Junya Okita; Johji Nagasaki; Naonori Harada; Yasutaka Aoyama; Takeo Kumura; Tadanobu Ohta; Yoshio Furukawa; Kazuhiro Takeuchi; Atsuko Mugitani
Journal:  Am J Blood Res       Date:  2013-12-18

3.  Chronic myeloid leukemia following the treatment of rectal adenocarcinoma.

Authors:  Gurhan Kadikoylu; Irfan Yavasoglu; Sabri Barutca; Nezih Meydan; Zahit Bolaman
Journal:  Med Oncol       Date:  2008-03-29       Impact factor: 3.064

4.  Chronic myelogenous leukemia and colon cancer: A causal relationship or coincidence?

Authors:  Theoni Kanellopoulou; Flora N Kontopidou; Maria Skondra; Kyriaki Pliarchopoulou; Dimitrios Pectasides
Journal:  Ann Gastroenterol       Date:  2011
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.